T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.

Although a favorable trend toward reduced distant recurrence in those patients treated with CC, the difference did not reach a statistical significance ( p = 0.094) (Figure 1 ).

also in 1,335 other papers